BlackRock Institutional Trust’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$16M Buy
3,867,795
+460,419
+14% +$2.45M ﹤0.01% 2130
2016
Q3
$27.6M Buy
3,407,376
+385,973
+13% +$3.28M ﹤0.01% 1658
2016
Q2
$23.6M Buy
3,021,403
+136,258
+5% +$1.17M ﹤0.01% 1747
2016
Q1
$22.3M Sell
2,885,145
-30,698
-1% -$225K ﹤0.01% 1756
2015
Q4
$31.5M Buy
2,915,843
+89,770
+3% +$816K 0.01% 1551
2015
Q3
$19.5M Buy
2,826,073
+109,962
+4% +$896K ﹤0.01% 1856
2015
Q2
$24.1M Sell
2,716,111
-158,528
-6% -$1.5M ﹤0.01% 1796
2015
Q1
$28.3M Buy
2,874,639
+343,036
+14% +$4.28M ﹤0.01% 1713
2014
Q4
$31M Sell
2,531,603
-77,962
-3% -$952K 0.01% 1622
2014
Q3
$26M Sell
2,609,565
-455,803
-15% -$4.23M ﹤0.01% 1718
2014
Q2
$23.2M Sell
3,065,368
-82,828
-3% -$330K ﹤0.01% 1859
2014
Q1
$10.4M Buy
3,148,196
+157,991
+5% +$553K ﹤0.01% 2399
2013
Q4
$9.92M Buy
2,990,205
+285,301
+11% +$828K ﹤0.01% 2423
2013
Q3
$8.17M Buy
2,704,904
+297,469
+12% +$2.04M ﹤0.01% 2483
2013
Q2
$19.7M Buy
+2,407,435
New +$18.4M ﹤0.01% 1822

Other funds holding ACHN